Provided by Tiger Fintech (Singapore) Pte. Ltd.

Armata Pharmaceuticals, Inc.

1.43
+0.08506.32%
Volume:12.53K
Turnover:18.30K
Market Cap:51.74M
PE:-1.61
High:1.48
Open:1.44
Low:1.41
Close:1.35
Loading ...

Company Profile

Company Name:
Armata Pharmaceuticals, Inc.
Exchange:
AMEX
Establishment Date:
- -
Employees:
60
Office Location:
5005 McConnell Avenue,Los Angeles,California,United States
Zip Code:
90066
Fax:
310 665 2963
Introduction:
Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is headquartered in Marina del Rey, California.

Directors

Name
Position
Deborah L. Birx
Chief Executive Officer, Director
Robin C. Kramer
Director and Chairman of the Board
Joseph M. Patti
Director
Jules Haimovitz
Director
Odysseas D. Kostas
Director
Sarah J. Schlesinger
Director
Todd C. Peterson
Director

Shareholders

Name
Position
Deborah L. Birx
Chief Executive Officer, Director
Julianne Averill
Chief Financial Officer
Mina Pastagia
Chief Medical Officer